WebApr 15, 2024 · Incyte (NASDAQ:INCY - Get Rating) last announced its quarterly earnings results on Tuesday, February 7th. The biopharmaceutical company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.59 by $0.03. Incyte had a net margin of 10.03% and a return on equity of 11.45%. The company had revenue of $926.70 million for … WebIncyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed Dow 30 33,485.29 +2.57(+0.01%) Nasdaq 12,087.96 +91.09(+0.76%) Russell 2000 … Discover historical prices for INCY stock on Yahoo Finance. View daily, weekly or … Find the latest Incyte Corporation (INCY) stock discussion in Yahoo Finance's … Get the detailed quarterly/annual income statement for Incyte Corporation (INCY). … Incyte Corporation 1801 Augustine Cut-Off Wilmington, DE 19803 United States 302 … View the basic INCY option chain and compare options of Incyte Corporation … See Incyte Corporation (INCY) stock analyst estimates, including earnings and … Find out all the key statistics for Incyte Corporation (INCY), including valuation … Find out the direct holders, institutional holders and mutual fund holders for … Incyte (INCY) receives approval for treating myeloid or lymphoid neoplasms using … Find the latest Incyte Corporation (INCY) stock quote, history, news and other vital …
INCY Insider Trading Activity Incyte Insider Buys and Sells
WebApr 4, 2024 · Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company was founded in April 1991 and is headquartered in Wilmington, DE. Recommended Stories Get a free copy of the StockNews.com research report on Incyte (INCY) WebMar 14, 2024 · Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of... chula vista construction brownsville tx
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims …
WebApr 13, 2024 · Incyte Stock Performance. Shares of NASDAQ INCY opened at $73.94 on Wednesday. The company has a current ratio of 3.54, a quick ratio of 3.50 and a debt-to-equity ratio of 0.01. Incyte has a 12 ... WebINCY Incyte Corp. Stock Price & News - WSJ Incyte Corp. INCY (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 04/06/23 $75.51USD 1.73 2.34% AFTER HOURS 7:34 PM EDT 04/06/23 … WebMar 7, 2024 · Incyte INCY announced that it will discontinue the late-stage LIMBER-304 study following the results of a pre-planned interim analysis conducted by an independent data monitoring committee (IDMC). chula vista courthouse hours